Cargando…
Selective Methylation of CpGs at Regulatory Binding Sites Controls NNAT Expression in Wilms Tumors
Aberrant expression of imprinted genes, such as those coding for the insulin-like growth factor 2 (IGF2) and neuronatin (NNAT), is a characteristic of a variety of embryonic neoplasms, including Wilms tumor (WT). In case of IGF2, it is generally accepted that loss of imprinting in a differentially m...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692448/ https://www.ncbi.nlm.nih.gov/pubmed/23825673 http://dx.doi.org/10.1371/journal.pone.0067605 |
_version_ | 1782274615986356224 |
---|---|
author | Hubertus, Jochen Zitzmann, Ferdinand Trippel, Franziska Müller-Höcker, Josef Stehr, Maximilian von Schweinitz, Dietrich Kappler, Roland |
author_facet | Hubertus, Jochen Zitzmann, Ferdinand Trippel, Franziska Müller-Höcker, Josef Stehr, Maximilian von Schweinitz, Dietrich Kappler, Roland |
author_sort | Hubertus, Jochen |
collection | PubMed |
description | Aberrant expression of imprinted genes, such as those coding for the insulin-like growth factor 2 (IGF2) and neuronatin (NNAT), is a characteristic of a variety of embryonic neoplasms, including Wilms tumor (WT). In case of IGF2, it is generally accepted that loss of imprinting in a differentially methylated region of the IGF2/H19 locus results in biallelic expression and, thus, upregulation of the gene. In this study we examined methylation pattern at potential regulatory elements of the paternally expressed NNAT gene in a cohort of WT patients in order to further characterize the molecular mechanism causing overexpression of this regulatory gene. We demonstrate that transcriptional upregulation of NNAT in WT is grossly independent of the bladder cancer-associated protein (BLCAP) gene, an imprinted gene within the imprinted domain of the NNAT locus. However, expression of the BLCAP transcript isoform v2a formerly known to be selectively expressed from the paternal allele in brain was associated with high expression of NNAT. This contrasts the situation we found at the IGF2/H19 locus, which shows high overexpression of IGF2 and inversely correlated expression of the H19 gene in WT. An analysis of DNA methylation in two potential regulatory regions of the NNAT locus by pyrosequencing revealed significant hypomethylation of the tumors compared to normal kidney tissue. Interestingly, the difference in DNA methylation was highest at CpGs that were observed within three putative binding sites of the CCCTC-binding factor CTCF. Most importantly, hypomethylation of both NNAT regulatory regions is significantly associated with the upregulation of NNAT expression and the BLCAP_v2a transcript. Our data indicate that the methylation status of a not-yet-described regulatory element within the NNAT locus that contains four potential CTCF binding sites determines the expression level of NNAT and the nearby located BLCAP_v2a transcript, thereby suggesting a functional role in the aberrant upregulation of NNAT in WT. |
format | Online Article Text |
id | pubmed-3692448 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-36924482013-07-02 Selective Methylation of CpGs at Regulatory Binding Sites Controls NNAT Expression in Wilms Tumors Hubertus, Jochen Zitzmann, Ferdinand Trippel, Franziska Müller-Höcker, Josef Stehr, Maximilian von Schweinitz, Dietrich Kappler, Roland PLoS One Research Article Aberrant expression of imprinted genes, such as those coding for the insulin-like growth factor 2 (IGF2) and neuronatin (NNAT), is a characteristic of a variety of embryonic neoplasms, including Wilms tumor (WT). In case of IGF2, it is generally accepted that loss of imprinting in a differentially methylated region of the IGF2/H19 locus results in biallelic expression and, thus, upregulation of the gene. In this study we examined methylation pattern at potential regulatory elements of the paternally expressed NNAT gene in a cohort of WT patients in order to further characterize the molecular mechanism causing overexpression of this regulatory gene. We demonstrate that transcriptional upregulation of NNAT in WT is grossly independent of the bladder cancer-associated protein (BLCAP) gene, an imprinted gene within the imprinted domain of the NNAT locus. However, expression of the BLCAP transcript isoform v2a formerly known to be selectively expressed from the paternal allele in brain was associated with high expression of NNAT. This contrasts the situation we found at the IGF2/H19 locus, which shows high overexpression of IGF2 and inversely correlated expression of the H19 gene in WT. An analysis of DNA methylation in two potential regulatory regions of the NNAT locus by pyrosequencing revealed significant hypomethylation of the tumors compared to normal kidney tissue. Interestingly, the difference in DNA methylation was highest at CpGs that were observed within three putative binding sites of the CCCTC-binding factor CTCF. Most importantly, hypomethylation of both NNAT regulatory regions is significantly associated with the upregulation of NNAT expression and the BLCAP_v2a transcript. Our data indicate that the methylation status of a not-yet-described regulatory element within the NNAT locus that contains four potential CTCF binding sites determines the expression level of NNAT and the nearby located BLCAP_v2a transcript, thereby suggesting a functional role in the aberrant upregulation of NNAT in WT. Public Library of Science 2013-06-25 /pmc/articles/PMC3692448/ /pubmed/23825673 http://dx.doi.org/10.1371/journal.pone.0067605 Text en © 2013 Hubertus et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Hubertus, Jochen Zitzmann, Ferdinand Trippel, Franziska Müller-Höcker, Josef Stehr, Maximilian von Schweinitz, Dietrich Kappler, Roland Selective Methylation of CpGs at Regulatory Binding Sites Controls NNAT Expression in Wilms Tumors |
title | Selective Methylation of CpGs at Regulatory Binding Sites Controls NNAT Expression in Wilms Tumors |
title_full | Selective Methylation of CpGs at Regulatory Binding Sites Controls NNAT Expression in Wilms Tumors |
title_fullStr | Selective Methylation of CpGs at Regulatory Binding Sites Controls NNAT Expression in Wilms Tumors |
title_full_unstemmed | Selective Methylation of CpGs at Regulatory Binding Sites Controls NNAT Expression in Wilms Tumors |
title_short | Selective Methylation of CpGs at Regulatory Binding Sites Controls NNAT Expression in Wilms Tumors |
title_sort | selective methylation of cpgs at regulatory binding sites controls nnat expression in wilms tumors |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692448/ https://www.ncbi.nlm.nih.gov/pubmed/23825673 http://dx.doi.org/10.1371/journal.pone.0067605 |
work_keys_str_mv | AT hubertusjochen selectivemethylationofcpgsatregulatorybindingsitescontrolsnnatexpressioninwilmstumors AT zitzmannferdinand selectivemethylationofcpgsatregulatorybindingsitescontrolsnnatexpressioninwilmstumors AT trippelfranziska selectivemethylationofcpgsatregulatorybindingsitescontrolsnnatexpressioninwilmstumors AT mullerhockerjosef selectivemethylationofcpgsatregulatorybindingsitescontrolsnnatexpressioninwilmstumors AT stehrmaximilian selectivemethylationofcpgsatregulatorybindingsitescontrolsnnatexpressioninwilmstumors AT vonschweinitzdietrich selectivemethylationofcpgsatregulatorybindingsitescontrolsnnatexpressioninwilmstumors AT kapplerroland selectivemethylationofcpgsatregulatorybindingsitescontrolsnnatexpressioninwilmstumors |